Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A1 | P04798 | 1/20 | 0.40 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.40 |
| ▸ | ERCC5 | P28715 | 1/20 | 0.39 |
| ▸ | FEN1 | P39748 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.38 |
| ▸ | CCNC | P24863 | 1/20 | 0.35 |
| ▸ | CDK8 | P49336 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | GUSB | P08236 | 1/20 | 0.34 |
| ▸ | ACVR1 | Q04771 | 2/20 | 0.34 |
| ▸ | GABRP | O00591 | 1/20 | 0.34 |
| ▸ | GABRD | O14764 | 1/20 | 0.34 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.34 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.34 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.34 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.34 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29326542 | 0.94 | CYP1A1 (0.42) | CYP1A1CYP1B1ERCC5FEN1KDM4E | |
| SCHEMBL27378779 | 0.89 | GRM4 (0.37) | CYP1A1CYP1B1ERCC5FEN1KDM4E | |
| SCHEMBL29326162 | 0.86 | CYP1A1 (0.53) | CYP1A1CYP1B1ERCC5FEN1KDM4E | |
| SCHEMBL29326533 | 0.85 | ERCC5 (0.39) | CYP1A1CYP1B1ERCC5FEN1KDM4E | |
| SCHEMBL27378774 | 0.83 | KDM4E (0.39) | CYP1A1CYP1B1ERCC5FEN1KDM4E | |
| SCHEMBL29326216 | 0.83 | ERCC5 (0.39) | CYP1A1CYP1B1ERCC5FEN1KDM4E | |
| SCHEMBL29326219 | 0.80 | ERCC5 (0.42) | CYP1A1CYP1B1ERCC5FEN1KDM4E | |
| SCHEMBL27192305 | 0.79 | CYP1A1 (0.37) | CYP1A1CYP1B1ERCC5FEN1KDM4E | |
| SCHEMBL29326530 | 0.79 | ERCC5 (0.42) | CYP1A1CYP1B1ERCC5FEN1KDM4E | |
| SCHEMBL29326453 | 0.79 | CYP1A1 (0.47) | CYP1A1CYP1B1ERCC5FEN1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240239807-A1 | SARS-COV2 MAIN PROTEASE INHIBITORS | GILEAD SCIENCES, INC. | 2024-07-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240239807-A1 | SARS-COV2 MAIN PROTEASE INHIBITORS | ACE2, TMPRSS2, ACE | CYP1A1 882/4885CYP1B1 1007/4885ERCC5 2042/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.